CME Group Inc
NASDAQ: CME · FINANCIAL SERVICES · FINANCIAL DATA & STOCK EXCHANGES
Updated 2026-06-12
CME Group Inc (CME) Financial statements
SEC filings — annual and quarterly data.
Margin trends — annual
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $1.09B | $407.35M | 72.47% | 56.96% | 37.37% |
| 2007 | $1.76B | $658.53M | 79.65% | 59.82% | 37.50% |
| 2008 | $2.56B | $715.49M | 80.42% | 61.78% | 27.94% |
| 2009 | $2.61B | $825.80M | 79.74% | 60.82% | 31.61% |
| 2010 | $3.00B | $951.40M | 84.26% | 60.96% | 31.67% |
| 2011 | $3.28B | $1.81B | 84.21% | 61.61% | 55.24% |
| 2012 | $2.91B | $896.30M | 81.58% | 58.05% | 30.75% |
| 2013 | $2.94B | $976.80M | 81.13% | 55.75% | 33.27% |
| 2014 | $3.11B | $1.13B | 81.23% | 56.82% | 36.21% |
| 2015 | $3.33B | $1.25B | 82.52% | 59.78% | 37.48% |
| 2016 | $3.60B | $1.53B | 84.89% | 61.21% | 42.67% |
| 2017 | $3.64B | $4.06B | 84.53% | 63.40% | 111.49% |
| 2018 | $4.31B | $1.96B | 84.40% | 60.51% | 45.53% |
| 2019 | $4.87B | $2.12B | 81.54% | 53.16% | 43.48% |
| 2020 | $4.88B | $2.11B | 82.46% | 54.01% | 43.11% |
| 2021 | $4.69B | $2.64B | 82.15% | 56.40% | 56.22% |
| 2022 | $5.02B | $2.69B | 85.00% | 60.08% | 53.61% |
| 2023 | $5.58B | $3.23B | 85.15% | 61.58% | 57.83% |
| 2024 | $6.13B | $3.53B | 86.13% | 64.13% | 57.52% |
| 2025 | $6.52B | $4.04B | 86.09% | 64.86% | 62.02% |
Frequently asked questions
What is CME Group Inc's revenue?
CME Group Inc's trailing twelve-month revenue is $6.74B. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.
How profitable is CME?
In its most recent fiscal year, CME ran a gross margin of 86.09%, an operating margin of 64.86%, and a net margin of 62.02%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.
How much free cash flow does CME generate?
CME produced $4.19B in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.
Is CME's balance sheet healthy?
CME holds $4.42B in cash and equivalents against $3.42B in long-term debt, on $28.73B of shareholder equity. Cash on hand exceeds long-term debt, so the balance sheet adds little financial risk to the thesis.